On behalf of the MDDMI 2017 steering committee and the conference chairman, Prof. Rafi Beyar, Director of the Rambam Health Care Campus, we are pleased to invite you to take part at the Israel’s premier event for medical device development. The steering Committee encourages the submission of original Papers for...

VAXIL BIO LTD. (TSX VENTURE: VXL) has reported  preliminary pre-clinical results demonstrating anti-cancer activity of Immucin™ in combination with checkpoint inhibitors. Furthermore, Vaxil’s scientists have made significant progress for Orphan Designated product Immucin™ in demonstrating its ability to act as a neo-antigen, with potential to strongly stimulate the immune system. Vaxil has launched...

GOUR Medical, an animal health specialist , has listed on Marché Libre Euronext Paris (ISIN code: CH0342399851; Ticker: MLGML), the French securities market. GOUR Medical is a pharmaceutical company dedicated to the development and marketing of veterinary drugs for mature pets. Having first identified and acquired a number of drug...

Alma is preparing a therapy for testing in patients with Crohn’s Disease.The company plans to conduct the early stage clinical testing. Then, Alma will license the therapy to a larger company and collect royalties from drug sales. </p> Crowdfunding has emerged as a solution and a major opportunity to find...

BioLineRx Ltd. (NASDAQ/TASE:BLRX) today announced the initiation of a Phase 2a trial investigating BL-8040 in combination with KEYTRUDA® (pembrolizumab), MSD’s anti-PD-1 therapy, in patients with metastatic pancreatic cancer. The Phase 2a study, named the COMBAT study, is an open-label, multicenter, single-arm trial designed to evaluate the safety and efficacy of...